Syncom Formulations: Founder-promoter Whole-Time Director resigns

Key managerial personnel resignedManagement Changes View source PDF Explain this filing

SYNCOMF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹15.28

prior close

₹15.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.6% vs market

Pharmaceuticals peers, median of 166sector-0.4%-2.1% vs sector

On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

-0.6

15m

-1.0

30m

-2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5+0.1-2.6-0.4-2.1

Next day

-0.3+0.2-0.5-0.5+0.2

+2.1+0.6+1.5-0.6+2.7

-0.1-0.0-0.1-1.4+1.3

+1.6+0.5+1.1-0.9+2.5

+6.3+0.8+5.6-0.4+6.8

+14.5+0.6+13.9-0.9+15.3

15d

+34.8+1.3+33.6+0.0+34.8

+21.5-1.4+22.8-0.1+21.6

+46.5-0.6+47.0-2.8+49.3

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 166Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Kedarmal Shankarlal Bankda, Founder and Promoter of Syncom Formulations, has resigned as Whole-Time Director effective 11 August 2026, citing succession planning, health and well-being. His association with the company spanned over five decades. The Board accepted his voluntary resignation, confirming no disagreement with management.

Likely market impact

Founder-promoter exit may cause short-term uncertainty. Voluntary, no governance issues. Watch for new leadership appointments.